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and syndromic vs. isolated). Delayed intervention for this treatable disease can result in permanent blindness due to amblyopia. Indeed, many children in low-income countries are blind because of untreated cataract (Medsinge and Nischal 2015) . The morbidity of pediatric cataract is also significant in higher income countries despite better access to surgical treatment, mostly driven by cases of delayed diagnosis (Zhang et al. 2012) .
The etiology of pediatric cataract is heterogeneous but genetic factors account for 8-29% of cases Hejtmancik 2007, 2013; Hejtmancik 2008) . All modes of inheritance have been reported, with autosomal dominant inheritance considered the most common form worldwide and autosomal recessive inheritance more common in the Middle East (Khan 2012 (Khan , 2013 Khan et al. 2015) . The online tool Cat-Map currently lists more than 38 genes that are mutated in isolated (non-syndromic) cataract (Shiels et al. 2010) . Genes encoding the crystalline family of proteins account for a substantial proportion of mutation-positive pediatric cataract cases. Genes encoding transcription factors that control early lenticular development such as EYA1 and PITX3 are also an important source of cataractlinked mutations. Interestingly, some genes are known to cause autosomal dominant as well as recessive forms of pediatric cataract depending on the nature of the mutation, e.g., BFSP2, TDRD7 and CRYAB (Aldahmesh et al. 2011; Safieh et al. 2009; Lachke et al. 2011) . Similarly, genes known to be mutated in syndromic forms of cataract have also been reported to cause apparently isolated cataract, e.g., AGK (Aldahmesh et al. 2012) .
Identification of causal mutations in pediatric cataract can greatly improve our understanding of the mechanisms that control normal lenticular development. Practical benefits of mutation identification include improved diagnostic accuracy, refined recurrence risk estimates as well as the possibility of prevention. Unfortunately, the remarkable clinical and genetic heterogeneity described above makes it challenging to provide molecular diagnosis for pediatric cataract patients. Fortunately, the advent of genomics tools enables the interrogation of a large number of genes simultaneously. The potential of this approach to improve the diagnostic yield in pediatric cataract has already been demonstrated in a number of studies (Gillespie et al. , 2016 Ma et al. 2016; Musleh et al. 2016) . The unbiased nature of this approach has unraveled the full phenotypic potential of known cataract genes and enabled the establishment of novel syndromic and isolated cataract genes (Aldahmesh et al. 2012) . In this study, we show the power of implementing genomics tools in the diagnostic workup of pediatric cataract patients. In addition to broadening the allelic spectrum of known cataract genes, we describe novel candidate genes. Further, we use eye gene expression databases such as iSyTE (integrated Systems Tool for Eye gene discovery) (Lachke et al. 2012) along with gene expression analysis in key mouse mutants that exhibit lens defects to indicate the potential regulatory pathways in which these newly identified cataract genes may function in the lens.
Materials and methods
Human subjects
All cataract patients seen in a pediatric ophthalmology clinic run by one of the authors (AOK) were eligible, regardless of family history. We have also enrolled a family referred from pediatric gastroenterology with unexplained lethal form of infantile liver disease and cataract. Informed consent was obtained from parents, and venous blood was collected from index and available family members as per an IRB-approved protocol (KFSHRC RAC# 2070023).
Multi-gene panel sequencing
A panel of 322 genes known to be mutated in various genetic eye conditions, including those involving cataract was designed as described before (Group SM 2015) . All index cases were initially run on this panel as a first-tier test. Details of the bioinformatics analysis are published elsewhere (Group SM 2015) . Variants were called according to the ACMG guidelines on variant interpretation.
Exome sequencing
All cases in which the multi-gene panel failed to identify a likely causal mutation were exome sequenced as described before (Group SM 2015) . The surviving variants were analyzed based on zygosity (depending on family pedigree), predicted pathogenicity based on SIFT, Polyphen and combined annotation-dependent depletion (CADD) scores (for missense variants), prioritizing truncating variants, location within the autozygome (for AR cases) and frequency below 0.01 within in-house (2200 exomes), and ExAC databases. All variants reported here have been confirmed by Sanger sequencing and segregation analysis was completed in all available family members.
Positional mapping
Positional mapping was carried out using autozygome analysis as described before (Alkuraya 2010 (Alkuraya , 2012 . Briefly, the Axiom SNP Chip platform was used for genome-wide genotyping followed by mapping regions of homozygosity (ROH) that are >2 Mb as surrogates of autozygosity. Where applicable, exome variants were filtered by the coordinates of the candidate autozygome as described before (Alkuraya 2013 (Alkuraya , 2016 .
Mouse lens expression analysis by iSyTE tool
To gain insights into the significance of each of the cataract-linked candidate genes in this study (TAPT1, RIC1, CYP51A1, GEMIN4, TAF1A and WDR87) we applied our published approach of using lens expression analysis (Lachke et al. 2012; Anand and Lachke 2016) . Mouse orthologs of these genes were investigated for their expression and enrichment in mouse lens expression microarrays datasets using iSyTE database (Lachke et al. 2012 ) and publicly available mouse lens microarray data. Expression intensities scores were computed at different stages of lens development stages, namely, E10.5, E16.5, P0, P28 and P56. In addition, lens-enrichment was estimated based on whole embryonic body (WB)-based in silico subtraction approach. The "R" statistical environment (http://www.rproject.org) was used to import raw microarray files, which were pre-processed and background corrected using Affy package available at Bioconductor (http://www.bioconductor.org) (Gautier et al. 2004) . Detailed analysis of microarrays is described elsewhere . Using RNA-seq data from mouse stage P0 (SRP040480) isolated lens epithelium (P0_epi) and fiber cells (P0_FC) (Hoang et al. 2014) , expression values in counts per million (CPM) were obtained and plotted to test differential expression of candidate genes in these cell types.
Gene expression analysis in targeted gene knockout mouse mutant lens datasets
The expression of candidate genes (Tapt1, Ric1, Cyp51a1, Gemin4, Taf1a and Wdr87) was investigated in various targeted gene knockout mouse mutants that exhibit lens defects. Mouse lens tissue gene expression microarray datasets from mutant animals for Pax6 conditional lens knockout (cKO) at E9.5 (GSE49227) and E10.5 (GSE49216); Brg1 (dominant negative dnBrg1 mutant) at E15.5 (GSE22322), Notch2 conditional lens knockout mutant at E19.5 (GSE31643), E2f1:E2f2:E2f3 (triple null conditional lens knockout mutant) at P0 (GSE16533), Hsf4 null at P0 (GSE22362), Sparc null at P28 (isolated lens epithelium) (GSE13402), Tdrd7 null at P30 (GSE25776), Klf4 null at P56 (GSE47694), and Mafg−/−:Mafk+/− compound mutants at P60 (GSE65500) were analyzed for differential expression of candidate genes. Further, transgenic mice over-expressing Foxe3 in fiber compartment at P2 (GSE9711) were also analyzed. Mutant lens tissues that exhibited significant differential expression of candidate genes (Tapt1, Ric1, Cyp51a1 Gemin4, and Taf1a) at p value ≤0.05 were plotted.
Candidate gene-network analysis using protein-protein interaction (PPI) data and iSyTE
To derive molecular insights for the identified candidate genes (Tapt1, Ric1, Cyp51a1, and Gemin4), we used an inhouse Python script to fetch out statistically significant PPI with proteins that function in the lens as well as potential new lens-expressed candidates from the String database (http://string-db.org). The obtained interactions were then subjected to lens expression and enrichment analysis at E10.5 lens dataset in iSyTE dataset described above, and visualized using Cytoscape.
Results
Clinical phenotypes
A total of 166 cataract patients comprising 74 families were enrolled in this study. The demographics of the study cohort are detailed in Table 1 . A positive family history was observed in 67%, and non-syndromic cataract was the most common presentation (72%). Both known and apparently novel forms of syndromic cataract were encountered (Table 1) . A few syndromic forms of cataract are worth highlighting. The first is related to what we initially reported in 2015 in several families who all shared the same founder mutation in GEMIN4. All patients shared global developmental delay and infantile cataract with or without renal involvement. Patient 14DG2265 provided independent confirmation of this association where his novel GEMIN4 mutation (NM_015721.2:c.314C>T;p. (Pro105Leu)) was associated with an identical phenotype (Table 1, Table S1 ). The mutation segregated within the family, and both parents are carriers, is absent in our database and predicted to be pathogenic by Polyphen, SIFT and CADD. Another recognizable syndrome was observed in 16DG0226 who was found at 1 week of age to have cholestatic jaundice and cataract, and was referred to our center for further evaluation. His physical examination showed growth parameters on the 5th percentile, icterus and bilateral cataract. His laboratory investigations revealed elevated liver enzymes (ALT 143, AST 518, alkaline phosphatase 729, GGT 167), AFP (>50,000), and ferritin (7994). Urine was negative for succinylacetone and reducing substances, and blood had normal isoelectric focusing of transferring. A liver biopsy revealed cholestasis with diffuse giant cell transformation and pseudorosettes. Parents are consanguineous and there is history of one sister who died at age of 2 months with liver failure. There was also positive family history on the paternal side of neonatal deaths in twins due to progressive cholestatic jaundice (see pedigree in Figure S1 , Table S1 ). By combining the index and his affected cousin, we were able to map this phenotype to a locus on Chr7: 80, 350, 103, 372 where exome sequencing revealed a mutation in CYP51A1 (NM_000786.3:c.695T>C;p.(Leu232Pro)). Finally, in two families with a syndromic form of cataract consisting of global developmental delay, microcephaly, brain atrophy with or without cleft lip and palate we were able to identify a candidate locus on Chr9:5629029-5778014 where exome sequencing revealed a shared founder mutation in RIC1 (NM_020829.3:c.3794G>C;p.(Arg1265Pro). Surprisingly, we also observed isolated cataract without aniridia in a patient with a novel de novo dominant PAX6 mutation (10DG1895).
Expanding the allelic spectrum of pediatric cataract
The multi-gene panel and exome sequencing identified a likely causal mutation in 58% of our cohort (not including candidate genes). The most commonly mutated group of genes was the crystalline genes, and one founder mutation in CRYBB1 was identified in 11 families (Table 1; Fig. 1) . Table 1 lists all the mutations identified in known cataract genes, including 15 that are novel (20%). Because the design of the multi-gene panel was in August 2013, cataract genes published after that date were not included but mutations therein were identified by exome sequencing, which we performed on all cases with a negative panel result. Of particular interest is LONP1, which we found to be mutated in five families, thus representing the second most commonly mutated gene in our cohort after the crystalline genes. Furthermore, we note that not all LONP1-related cataract cases were syndromic, which suggests that LONP1 is yet another example of genes that can be mutated in both syndromic and non-syndromic forms of cataract.
Expanding the genetic heterogeneity of pediatric cataract
In addition to revealing mutations in known cataract genes that postdate the design of the multi-gene panel, exome sequencing of negative panel cases revealed, as expected, mutations in candidate genes. Specifically, we confirmed GEMIN4 as a disease gene for the syndrome of cataract and global developmental delay (Alazami et al. 2015) . The same founder mutation in GEMIN4 was identified in 10DG0703 who was previously reported to have a missense variant in MFSD6L, thus disproving the link proposed between cataract and MFSD6L, at least in that patient (Aldahmesh et al. 2012 
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GCNT2 (2) RIC1 (2) SIL1 (2) AGK (1) AKR1E2 (1) BFSP2 (1) CRYAA (1) CRYAB (1) CRYBA1 (1) CRYBB1 (1) CRYGC (1) CRYGD (1) CYP27A1 (1) ERCC2 (1) GALT (1) GJA8 (1) GNPAT (1) LEPREL1 (1) MIP (1) NHS (1) PAX6 (1) PXDN (1) RAB3GAP1 (1) RNLS (1) SLC16A12 (1) TAF1A (1) TAPT1 (1) Fig. 1 Expanding the allelic and locus heterogeneity of pediatric cataract. Distribution for mutations identified in known and novel candidate genes for cataract by NGS pseudodominant inheritance of a novel missense variant in this gene (Khan et al. 2015; Aldahmesh et al. 2012) . Subsequently, another group reported a mutation in this gene in a patient with cataract and liver disease . Thus, our finding of an independent mutation in 16DG0226 ( Figure S1 ) confirm CYP51A1 as a disease gene for the syndrome of cataract and cholestatic liver disease, although it can also be mutated in patients with isolated cataract.
In family 12DG2657, we were also able to map isolated cataract phenotype to a single locus (Chr4:13944470-16401420), in which exome sequencing revealed a splicing variant in the novel candidate TAPT1 (NM_153365.2:c.846 + 2insT). RTPCR confirmed the partially truncating nature of this variant (NM_153365.2:r.712_846del), ( Figure S2 ). Furthermore we were able to identify the same mutation (NM_020829.3:c.3794G>C;p.(Arg1265Pro)) in the novel candidate RIC1 in two apparently unrelated patients (07DG-0035/10DG1320 and 15DG2427) who nonetheless shared one autozygous interval thus confirming the founder nature of this mutation ( Figure S3 ).
In addition to the above genes whose candidacy is supported by independent mutations (GEMIN4 and CYP51A1) or linkage analysis (TAPT1 and RIC1), exome sequencing also revealed homozygous truncating variants in two genes not previously linked to cataract. In patient 11DG2176, who presented with global developmental delay, unexplained hepatomegaly and cataract, we identified a homozygous frameshift deletion in TAF1A (NM_001201536.1:c.40_41del;p.(Asp14*)) ( Figure S4 ). Patient 12DG2386, on the other hand, and his sibling presented with isolated congenital cataract and both were found to have a homozygous nonsense mutation in WDR87 (NM_031951.4:c.856G>T;p.(Glu286*)) ( Figure S5 ).
The candidate cataract genes are expressed in lens development
We next sought to investigate the relevance of the newly identified cataract-linked genes to lens biology. We first analyzed mouse lens microarray datasets at embryonic, early postnatal and late postnatal stages to examine the expression of Tapt1, Ric1, Cyp51a1, Gemin4, Taf1a and Wdr87 during lens development. Tapt1 is expressed in lens tissue at E10.5, E16.5, P0, and P56, and exhibits a trend toward high expression with developmental progression. Further, its expression was found to be high in P28 isolated lens epithelium as well (Fig. 2a) . Ric1 was expressed in the lens at all stages examined, albeit at low comparable levels, except in isolated lens epithelial cells where it exhibited higher expression (Fig. 2a) . Cyp51a1 was highly expressed in lens tissue at E10.5, E16.5, P0 and P56, and while it was also expressed in isolated lens epithelium, its levels are low in these cells compared to the whole lens tissue (Fig. 2a) . Gemin4 exhibited an expression trend that is high in early lens development at E10.5 and became progressively low in subsequent stages (Fig. 2a) . Lens microarray indicates that Taf1a is expressed in various stages of mouse lens development (Fig. 2a) . Finally, WDR87 mouse ortholog, 4932431P20Rik, is also expressed in the lens albeit at lower levels (Fig. 2a) .
Next, we investigated if these candidate genes exhibit enriched expression in the lens as described (Lachke et al. 2012; Anand et al. 2015) . Tapt1 is significantly enriched in the lens from embryonic stage E16.5 through P56, with highest lens-enrichment in the P28 lens epithelium (Fig. 2b) . Similarly, Taf1a exhibits enriched expression in several stages of lens development, namely, at E10.5, P0, P56 as well as in P28 lens epithelium (Fig. 2b) . Ric1 is enriched only in the P28 lens epithelium, while Cyp51a1 and Gemin4 exhibit lens-enrichment in embryonic stages E16.5 and E10.5, respectively (Fig. 2b) .
We also examined RNA-seq data from newborn mouse lens epithelium and fiber cells to investigate if these genes are expressed within specific lenticular cell types. We find that while Tapt1 is significantly expressed in both cell types in the lens, its expression in the epithelium is significantly higher compared to that in fiber cells (Fig. 2c) . In contrast, Cyp51a1 and Ric1 that are also expressed in both lens cell types, exhibit significantly high expression in fiber cells compared to epithelial cells (Fig. 2c) . Gemin4 expression in both lens cell types was low in newborn mouse lenses (Fig. 2c) , in agreement with the trend of low expression with lens development progression from embryonic to postnatal stages as observed in the microarray analysis. While Taf1a expression was found to be higher in fiber cells compared to epithelial cells, 4932431P20Rik (WDR87) expression in both cell types was found to be low and not significantly different (Fig. 2c) .
The candidate cataract genes are mis-expressed in key gene knockout mice with lens defects
We next sought to investigate whether Tapt1, Ric1, Cyp51a1, Gemin4, Taf1a and 4932431P20Rik (Wdr87) were affected in different gene knockout mouse mutants that exhibited defects in lens development. Tapt1 was significantly down-regulated in Pax6 conditional lens knockout (Pax6 cKO) mouse lenses at E9.5, Notch2 conditional lens knockout (Notch2 cKO) mouse lenses at E19.5 and E2f 1−/−:E2f2−/−:E2f3−/− triple conditional lens knockout (E2f1/2/3 cKO) mouse lenses at P0 (Fig. 3) . Ric1 was down-regulated in Pax6 cKO lenses at E9.5 and E10.5, and up-regulated in Sparc null lens epithelium (Fig. 3) . Cyp51a1 exhibited mis-regulation in both directions in different gene knockout mouse lenses. In Brg1 mutant (dnBrg1 mutant) lenses at E15.5 and E2f1/2/3 cKO mouse lenses at P0, Cyp51a1 exhibited significantly reduced expression (Fig. 3) . Further, in transgenic mice that overexpress the lens epithelial transcription factor Foxe3 in lens fiber cells, Cyp51a1 expression was significantly reduced as well (Fig. 3) . However, in stage P30 Tdrd7 null mouse lenses, P56 Klf4 conditional lens knockout (Klf4 cKO) mouse lenses, as well as P60 Mafg−/−:Mafk+/− compound mouse mutant lenses Cyp51a1 was significantly up-regulated (Fig. 3) . Gemin4 was found to be significantly reduced in Cpb:p300 conditional lens knockout (Cpb:p300 cKO) mice at E10.5 (Fig. 3) . Taf1a was found to be down-regulated in E15.5 dnBrg1 and P0 Hsf4 null mouse mutants, both of which exhibit lens defects (Fig. 3) . Finally, 4932431P20Rik (WDR87) was not identified to be mis-regulated in any of the mouse mutant datasets tested.
The candidates interact with proteins with known lens function or expression
To investigate if the new cataract associated candidates may potentially interact with proteins that are known to function in the lens or exhibit lens expression, we performed an integrated analysis with publically available protein-protein interaction (PPI) data and overlay of iSyTE lens gene 
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RNA-seq (CPM) RNA-seq (CPM) * Fig. 2 The mouse orthologs of the novel cataract candidate genes TAPT1, RIC1, CYP51A1, GEMIN4, TAF1A, WDR87 (4932431P20Rik) are expressed and enriched in lens development. a Lens expression of candidate genes Tapt1, Ric1, Cyp51a1, Gemin4, Taf1a, and 4932431P20Rik (WDR87) was analyzed in whole lens microarray datasets at mouse embryonic day (E) 10.5, E16.5 and postnatal day (P) 0, and P56, as well as isolated lens epithelium (Epi.) dataset at P28. The red dotted line in a indicates expression cut-off score of 100 fluorescence intensity units. b Lens-enrichment of candidate genes was evaluated by comparing their fluorescence expression intensity scores in the lens against that in the mouse whole embryonic body (WB) reference dataset. The color intensities in the heat map indicate the fold-change differences between lens expression over WB. c RNA-seq expression of newborn (P0) mouse isolated lens epithelium (epi) and fiber cells (FC). Error bars represent standard error of mean (SEM). Asterisk represents significant difference between comparisons in FC and Epi. expression (p < 0.05) expression data. Further, we investigated these networks for functional gene-ontology (GO) categories. Together, these analyses led to insights into their established connectivity with other candidates that are involved in lens defects or which may be expressed in the lens. This approach led to the outlining of 22 direct interacting partners of the nonsyndromic cataract candidate TAPT1 ( Figure S6A, B) . Further, from a total of 39 direct protein-protein level connections of the non-syndromic cataract candidate RIC1, 32 candidates were expressed in the lens, of which 14 were lens-enriched including GJA1, which had been shown to interact with RIC1 and mutations of which cause microphthalmia and cataract (Akiyama et al. 2005; Paznekas et al. 2003) (Figure S6C, D) . This approach also revealed that the syndromic cataract candidate GEMIN4 is connected to 53 partners, of which 50 candidates exhibit lens expression and 37 exhibit lens-enrichment ( Figure S7A, B) . Similarly, CYP51A1, which is known to be involved in the synthesis of cholesterol, steroids and other lipids, is connected to 51 direct interactors, of which 35 candidates exhibit lens expression and 22 exhibit lens-enrichment ( Figure S7C , D). As expected, GO analysis of the CYP51A1-PPI network reveals an enrichment for sterol biosynthetic process (GO:0016126) categories that includes 15 protein-protein interaction candidates, namely, TM7SF2, MVD, HMGCR, HSD3B7, HMGCS1, LSS, FDFT1, DHCR7, HSD17B7, NSDHL, DHCR24, FDPS, SIGMAR1, SQLE, MVK, that are expressed in the lens. Earlier studies on sterol profiling of the affected individuals with cataract and other eye disorders with causal mutation identified in CYP51A1, CYP27A1, SC5D, DHCR7 genes clearly suggest their role in sterol biosynthetic process/pathways (Gillespie et al. 2016) . Further, CYP51A1 is directly connected to ALDH1A1 and MAFG, both of which are linked to cataracts Lassen et al. 2007 ).
Discussion
Molecular characterization of pediatric cataract has many practical applications. It provides accurate diagnosis, ends an otherwise expensive and protracted diagnostic odyssey and empowers families to make informed reproductive choices. Molecular diagnosis also has the potential to alter patient management. One good example is patient 13DG2254 whose cataract was found to be caused by a novel GALT mutation prompting urgent referral to the metabolic specialist for close dietary management of galactosemia. The marked clinical and genetic heterogeneity of pediatric cataract often complicates clinically-guided molecular testing, although this is quickly changing with the advent of clinical genomics. In this study, we show GEMIN4 is an intron-less gene that encodes Gem (nuclear organelle)-associated protein 4, a ubiquitously expressed component of the Gemin protein complex that also includes SMN1 and the core components Gemin proteins 2, 3, 5, 6, 7 and 8 as well as Unrip (Charroux et al. 2000; Lorson et al. 2008) . The complex is known to associate with the spliceosomal complex U snRNP (Fischer et al. 1997) . The exact biological role of the complex is unknown so it is unclear how deficiency of GEMIN4 can lead to the syndrome of global developmental delay and congenital cataract, and whether or not this mediated through perturbation of the complex. However, our finding of two independent homozygous mutations in GEMIN4 in patients with a similar phenotype strongly implicates GEMIN4 in the etiology of this syndrome.
CYP51A1 encodes lanosterol 14α-demethylase, an enzyme that catalyzes a late step in cholesterol synthesis (Acimovic and Rozman 2013) . Complete deficiency of the murine ortholog is embryonic lethal, which may explain why all the mutations, with the exception of one heterozygous stop-gain, observed thus far in this gene are all missense, rather than truncating (Keber et al. 2011) . The hepatocyte-specific Cyp51 partial KO mice display poor weight gain, increased liver/body size ratio as well as severe liver inflammation and fibrosis, findings reminiscent of the phenotype we observe in patient 16DG0226, as well as the family reported by Gillespie et al. ( , 2016 (Lorbek et al. 2015) . Further, other genes such as CYP27A1, SC5D, DHCR7, which encode enzymes involved in cholesterol and sterol biosynthesis are also linked with syndromic cataract. Thus, accumulation of precursor metabolites such as lanosterol in the lens and liver may be causative of tissuespecific defects observed in the patient in the present study.
The link between TAPT1 and cataract was unexpected. TAPT1 encodes transmembrane anterior posterior transformation 1 protein that was found by Symoens et al. to be mutated in two families with osteogenesis imperfectalike skeletal dysplasia (Symoens et al. 2015) . On the other hand, the family we describe in which cataract maps to a single locus in which a homozygous splicing TAPT1 mutation was identified did not have any evidence of skeletal involvement. It is possible that the apparent discrepancy in phenotype represents a genuine example of allelism especially since both our mutation and that identified by Symoen cause in-frame truncations mediated by entire exon skipping (exon 6 in this report and 10 in Symoen's).
Future cataract patients with different mutations in TAPT1 will help clarify the true phenotypic spectrum. Similar to TAPT1, we have identified RIC1 as a novel cataract candidate based on strong positional mapping data that point to a single locus. Significantly, the connection in the PPIbased network between RIC1 and the cataract-linked gene GJA1 was due to an established direct interaction between these proteins as shown by a previous study (Akiyama et al. 2005) . Further, that study also showed that knockdown of RIC1 resulted in defective localization of GJA1 to gap junctions, affecting gap junction conductivity, which may offer a potential explanation for the cataract associated with RIC1 mutations.
We have previously shown that the mutation spectrum of genetically heterogeneous diseases is dominated by autosomal recessive mutations in our highly inbred populations Anazi et al. 2016; Alazami et al. 2016) . We show in this study that cataract displays a similar trend with recessive mutations accounting for 87% of all identified mutations. Interestingly, we show that some cataract genes that had only been reported to cause the disease in a dominant fashion, can also cause autosomal recessive cataract, e.g., EPHA2 in patient 10DG0428. These examples are very helpful in shedding light on the molecular pathogenesis of these genes since they can challenge the notion of haploinsufficiency of dominant mutations when carriers of loss of function recessive mutations (parents) appear normal.
It has been shown that enriched expression in developing lens tissue can be used as a criterion to evaluate potential function in lens development (Lachke et al. 2011 (Lachke et al. , 2012a Anand and Lachke 2016; Anand et al. 2015; Agrawal et al. 2015; Kasaikina et al. 2011; Wolf et al. 2013; Manthey et al. 2014; Dash et al. 2015; Audette et al. 2016) . Consistent with those data, we find that all six candidates are significantly expressed in mouse lens development, and five exhibit lens-enrichment. We also examined microarray data from several targeted gene mouse mutants lens/presumptive lens tissue for their expression of these candidate genes, and performed PPI analysis. Several interesting observations emerged from these analyses. For example, the downregulation of Tapt1 and Ric1 in Pax6 cKO presumptive lens ectoderm suggests that these genes are expressed early in lens development. Similarly, Tapt1 is down-regulated in Notch2 cKO lens indicating that Tapt1 is under Notch signaling pathway, which is essential for proper lens development. We note that Cyp51a1 is abnormally expressed in Mafg−/−:Mafk+/−, which exhibit mis-regulation of genes involved in the sterol synthesis pathway . PPI network analysis for Cyp51a1 independently shows an enrichment for sterol biosynthetic process, which is particularly significant because lanosterol synthase mutations can cause cataracts in humans and rat (PMC1350995) and the sterol pathway is important for maintenance of lens transparency by prevention of protein aggregation in the lens (Makley et al. 2015; Zhao et al. 2015) . Thus, analysis of specific gene perturbation mouse mutants that exhibit lens defects demonstrated mis-regulation of these newly identified cataract genes, and PPI analysis revealed novel connections that is suggestive of function in lens development.
In conclusion, we show the value of applying research and clinical genomics in the analysis of pediatric cataract, which in turn will lead to improved diagnostic accuracy in the near future. Our study confirms the candidacy of some previously reported novel genes as well as adds a number of novel candidates whose potential role in lenticular development and cataract should be verified by future studies.
